Japan· JP-1319408A1020
ファリシマブ（遺伝子組換え）
A medicinal product containing ファリシマブ（遺伝子組換え）, registered in Japan by 中外製薬, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- ファリシマブ（遺伝子組換え）
- Manufacturer
- 中外製薬
- Country
- Japan (JP)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
ファリシマブ（遺伝子組換え） in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandVabysmoAbacus Medicine A/S
- SpainVABYSMO 120 MG/ML SOLUCION INYECTABLERoche Registration Gmbh
- CzechiaVABYSMORoche Registration GmbH, Grenzach-Wyhlen
- BelgiumVabysmo 120 mg/mlRoche Registration
- SwitzerlandVabysmo 6 mg/0,05 ml, InjektionslösungRoche Pharma (Schweiz) AG
- United KingdomVabysmo 21mg/0.175ml solution for injection pre-filled syringesRoche Products Ltd
- IrelandVabysmo 120 mg/mL solution for injectionRoche Registration GmbH
- IcelandVabysmoRoche Registration GmbH*
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Vabysmo
- Liechtenstein · Vabysmo
- Norway · Vabysmo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5bff1651-4935-468b-b58e-e108d0937b0b GET /v1/drugs/5bff1651-4935-468b-b58e-e108d0937b0b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "６ｍｇ０．０５ｍＬ１瓶",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "1319408A1020",
"category": "注射薬",
"price_yen": 141784,
"generic_name": "ファリシマブ（遺伝子組換え）",
"product_name_jp": null,
"therapeutic_class": "1319",
"transitional_expiry": null
}See everything about ファリシマブ（遺伝子組換え）.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.